Inflammopharmacology logo VSP, an imprint of Brill logo

Publisher: VSP, an imprint of Brill

Volume 13, Number 4, 2005
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Introduction — The coxib controversies
pp. 331-341(11)
Author: Rainsford, K.D.

The use of NSAIDs in rheumatic disorders 2005: a global perspective
pp. 343-370(28)
Authors: Kean, Walter F.; Buchanan, W. Watson

The murky waters of the coxibs: a review of the current state of play
pp. 371-380(10)
Authors: Ostor, Andrew J.K.; Hazleman, Brian L.

The murky world of the COX-2-selective agents
pp. 381-393(13)
Authors: Bjarnason, Ingvar; Thjodleifsson, Bjarni

COX-2 controversy: where are we and where do we go from here?
pp. 395-402(8)
Authors: Khanna, Dinesh; Khanna, Puja P.; Furst, Daniel E.

Coxibs and their aftermath: an (opinionated) commentary, based on some historical viewpoints
pp. 403-417(15)
Author: Whitehouse, M.

COX-2 inhibitors: a story of greed, deception and death
pp. 419-425(7)
Author: Halpern, Georges M.

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A